Oramed Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68403P2039
USD
3.50
-0.05 (-1.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
0.00
0.00
2.00
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.00
0.00
2.00
0.00
0.00
0.00
0.00
Raw Material Cost
0.03
0.03
2.02
0.03
0.05
0.05
0.06
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.26
0.59
Selling and Distribution Expenses
1.24
1.43
2.28
2.10
0.80
1.64
1.78
Other Expenses
0.12
0.10
0.22
0.15
0.22
0.12
0.05
Total Expenditure (Excl Depreciation)
2.43
2.49
6.50
3.60
3.09
3.14
2.96
Operating Profit (PBDIT) excl Other Income
-2.4
-2.5
-4.5
-3.5999999999999996
-3.1
-3.1
-3
Other Income
41.91
8.49
-2.56
-6.19
-15.42
14.23
5.09
Operating Profit (PBDIT)
39.52
6.03
-7.03
-9.75
-18.46
11.15
2.18
Interest
0.00
0.00
0.00
0.00
0.00
0.26
0.59
Exceptional Items
19.96
7.14
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
-0.03
-0.03
-0.02
-0.03
-0.05
-0.05
-0.06
Depreciation
0.03
0.03
0.03
0.03
0.05
0.05
0.06
Profit Before Tax
59.45
13.13
-7.06
-9.78
-18.51
10.84
1.53
Tax
11.06
-0.13
0.58
0.42
1.13
1.63
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
48.40
13.29
-7.64
-10.19
-19.62
9.21
1.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
48.40
13.29
-7.64
-10.19
-19.62
9.21
1.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.01
-0.03
0.00
-0.01
-0.02
-0.01
-0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
48.39
13.26
-7.64
-10.20
-19.64
9.20
1.53
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
203.28
154.53
140.81
146.26
156.44
177.06
166.64
Earnings per share (EPS)
1.13
0.31
-0.19
-0.26
-0.48
0.22
0.04
Diluted Earnings per share
1.13
0.31
-0.19
-0.26
-0.48
0.22
0.04
Operating Profit Margin (Excl OI)
0.0%
0.0%
-225.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
-351.4%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
-382.1%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 263.91% vs 275.00% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 4.00% vs 44.44% in Jun 2025

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Oramed Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
0.00
168.45
-168.45
-100.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.00
168.45
-168.45
-100.00%
Raw Material Cost
0.03
27.85
-27.82
-99.89%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
22.64
-22.64
-100.00%
Selling and Distribution Expenses
1.24
41.43
-40.19
-97.01%
Other Expenses
0.12
-0.87
0.99
113.79%
Total Expenditure (Excl Depreciation)
2.43
83.21
-80.78
-97.08%
Operating Profit (PBDIT) excl Other Income
-2.43
85.23
-87.66
-102.85%
Other Income
41.91
1.07
40.84
3,816.82%
Operating Profit (PBDIT)
39.52
86.33
-46.81
-54.22%
Interest
0.00
22.64
-22.64
-100.00%
Exceptional Items
19.96
0.00
19.96
Gross Profit (PBDT)
-0.03
140.59
-140.62
-100.02%
Depreciation
0.03
0.03
0.00
Profit Before Tax
59.45
63.67
-4.22
-6.63%
Tax
11.06
1.84
9.22
501.09%
Provisions and contingencies
0
0
0.00
Profit After Tax
48.40
61.83
-13.43
-21.72%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
48.40
61.83
-13.43
-21.72%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.01
0.00
-0.01
Other related items
0.00
0.00
0.00
Consolidated Net Profit
48.39
61.83
-13.44
-21.74%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
203.28
-301.96
505.24
167.32%
Earnings per share (EPS)
1.13
0.22
0.91
413.64%
Diluted Earnings per share
1.13
0.22
0.91
413.64%
Operating Profit Margin (Excl OI)
0.00%
50.60%
0.00
-50.60%
Gross Profit Margin
0.00%
37.82%
0.00
-37.82%
PAT Margin
0.00%
36.71%
0.00
-36.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Markets Mojo
No Net Sales in the last few periods
Quarterly - Consolidate Net Profit
Consolidate Net Profit 4.84 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 263.91% vs 275.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 346.94% vs -493.94% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.24 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 4.00% vs 44.44% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 20.00% vs -7.14% in Sep 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Markets Mojo
No Operating Profit Margin (Excl OI) in the last few periods